Track AMRX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a earnings per share of $0.27, up 28.6% over the past year.
Latest EPS (Actual)
$0.27
Beat Rate
87.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | $0.19 | $0.27 | Beat | +38.96% |
| Feb 2026 | $0.18 | $0.21 | Beat | +16.67% |
| Oct 2025 | $0.14 | $0.17 | Beat | +21.43% |
| Aug 2025 | $0.17 | $0.25 | Beat | +47.06% |
| May 2025 | $0.15 | $0.21 | Beat | +40.00% |
| Feb 2025 | $0.15 | $0.12 | Miss | -20.00% |
| Nov 2024 | $0.14 | $0.16 | Beat | +14.29% |
| Aug 2024 | $0.14 | $0.16 | Beat | +14.29% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.